ライフサイエンスコーパス: dose equivalent

1 d with 1-1500 mg in fluoxetine hydrochloride dose equivalents).

2 to 1%-7% of the allowed annual occupational dose equivalent.

3 be crucial to calculations of the effective dose equivalent.

4 the cumulated activity to yield the absorbed dose equivalent.

5 hort-acting metoprolol tartrate at different dose equivalents.

6 The effective dose equivalent (0.0120 mGy/MBq) is also lower than comp

7 D of cediranib was 12 mg/m(2)/d (adult fixed dose equivalent, 20 mg).

8 An approximately 40% reduction in the dose equivalent across all staff members occurred during

9 Effective dose equivalents also were estimated using ionization ch

10 Estimates of the effective dose equivalent and doses for specific organs were made

11 The effective dose equivalent and effective dose averages were lower i

12 The effective dose equivalent and effective dose for (123)I-ADAM were

13 The effective dose equivalent and effective dose for (123)I-IMPY were

14 tients were individually matched on both the dose equivalents and the respective propensity scores fo

15 e report measurements of the radiation dose, dose equivalent, and linear energy transfer spectra.

16 confinement (i.e., below which the effective dose equivalent at 1 m will not exceed the maximum recom

17 Effective dose equivalent (EDE) was calculated using International

18 The dose equivalent for even the shortest round-trip with cu

19 g the RESRAD model showed that the radiation dose equivalent for the baseline conditions was well bel

20 iscuss measurements of the absorbed dose and dose equivalent from galactic cosmic rays and solar ener

21 .75) and adjustment for propensity score and dose equivalents (hazard ratio, 1.06; 95% confidence int

22 7% for each increase of five bisphosphonate dose equivalents (HR = 1.07; 95% CI, 1.02 to 1.12).

23 prodrug carrier alone (mPEG); 2) 0.5 mg SIM dose equivalent in carrier (SIM/SIM-mPEG); 3) 1.0 mg SIM

24 The average monthly dose equivalent in millirems (1 mrem = 0.01 mSv) was rec

25 rathecal doses of nusinersen (6 mg and 12 mg dose equivalents) in patients with infantile-onset spina

26 Radiation dose equivalent levels were reduced in period 2 to 1%-7%

27 0.94-1.20; P=0.36) or in the propensity and dose equivalent-matched sample (hazard ratio, 1.00; 95%

28 Skill Acquisition Program [ASAP]; n = 119); dose-equivalent occupational therapy (DEUCC; n = 120); o

29 555 MBq (15 mCi) will result in an effective dose equivalent of 5.9 mSv (0.59 rem) and a lung dose of

30 an adult human male would yield an effective dose equivalent of approximately 13.5 mSv, roughly equiv

31 Median effective dose equivalent of inhalational anesthetics during surge

32 lantation of CD8(+)Vbeta13(+) T cells at the dose equivalent of their constituency in 1 x 10(7) CD8(+

33 At oral daily dose-equivalent of 3 mg/kg, 12 exhibited analgesic effic

34 bserved, yielding an overall average mission dose-equivalent of about 150 millirems, more than three

35 tatin doses (by 0.44 mm(2)/10 mg simvastatin dose equivalent; P = .02).

36 om a point source in air predicted using the dose equivalent rate per unit activity of (131)I (5.95 x

37 d from green tea (GTP) at a human achievable dose (equivalent to six cups of green tea per day) signi

38 s or continuous infusion and at either a low dose (equivalent to the patient's previous oral dose) or

39 netic study was performed to determine the L dose equivalent to 1,000 mg in humans.

40 Mice were protected from a dose equivalent to 1,000 to 10,000 50% lethal doses (LD(

41 ed up to 2 h following exposure of mice to a dose equivalent to 10 LD(50) of BoNT/A.

42 ollowing in vitro radiation with a radiation dose equivalent to 10 mGy (1).

43 A dose equivalent to 15 mg/kg of ferric carboxymaltose was

44 single i.v. injection of the conjugate at a dose equivalent to 160 mg of paclitaxel/kg.

45 or L45R, resulted in nonlethal proteins at a dose equivalent to 30 murine LD50 of SEB.

46 o 60 mg of paclitaxel/kg and at even a lower dose equivalent to 40 mg of paclitaxel/kg resulted in th

47 em in a mouse model of pneumonic plague at a dose equivalent to 5 50% lethal doses (LD50) of wild-typ

48 of body-surface area) and carboplatin (at a dose equivalent to an area under the concentration-time

49 urface area every 3 weeks, plus carboplatin (dose equivalent to an area under the curve [AUC] of 6) f

50 sing the measured dose rate method, the mean dose equivalent to an individual exposed to the same RIT

51 The expected effective dose equivalent to an individual from contact with 131I

52 now release patients if the total effective dose equivalent to another individual from exposure to a

53 now release a patient if the total effective dose equivalent to another individual from exposure to t

54 domization (2:1) to aldoxorubicin 350 mg/m2 (dose equivalent to doxorubicin 260 mg/m2) or doxorubicin

55 Remarkably, monthly P-Dex administration (dose equivalent to free Dex treatment) was equally effec

56 The absorbed dose equivalent to liver and spleen volumes ranged from

57 e results, leaving 17 who were negative to a dose equivalent to over 375 mg of aspirin.

58 (control) (MIN) or cattle manure at a single dose equivalent to potassium fertilizer (ORG) or double

59 dexamethasone phosphate sodium (Dex; overall dose equivalent to that of P-Dex) for 2 months.

60 injected via the intraperitoneal route at a dose equivalent to that of the 30-s intranasal concentra

61 ation of guinea pigs with UL24-betagluc at a dose equivalent to the LD50 of parental virus (approxima

62 ing for the attenuation of photons, the mean dose equivalent to the public exposed to an 131I anti-B1

63 ificantly reduces the occupational radiation dose equivalent to the staff of a nuclear cardiology lab

64 nd level of response as elicited by a single dose equivalent to the total of the fractionated doses.

65 The estimate of radiation dose equivalent to the urinary bladder wall (ca. 180 +/-

66 DeltaPT bacteria were inoculated at a dose equivalent to the WT dose and at a high dose (Delta

67 Effective dose equivalents to members of the public were estimated

68 l was effective over a range of oral antigen doses (equivalent to 5-80 microg recombinant F.IX/kg), a

69 At high doses (equivalent to more than 2 cups of coffee or four

70 intained for several hours after single oral doses equivalent to 10% to 20% of doses required for but

71 s) were challenged by the aerosol route with doses equivalent to approximately 100 50% effective dose

72 cytokine release in different cell lines at doses equivalent to exposure durations from 7.8 to 1,500

73 but patients with no chemotherapy still had doses equivalent to five tablets per day of 5-mg hydroco

74 f both total venom and constituent porins at doses equivalent to lethal envenomation.

75 Free chlorine doses equivalent to the 24 hour endpoint concentration f

76 uses and limitations of COX-2 inhibition at doses equivalent to those currently approved for use in

77 [interquartile range])-fold median effective dose equivalent versus 0.57 (0.45-0.64)-fold median effe

78 voiding intervals, 1-2 h), and the effective dose equivalent was 0.00177 +/- 0.000152 cSv/MBq.

79 The effective dose equivalent was 0.0106 mSv/MBq (0.0392 rem/mCi).

80 Effective dose equivalent was 0.013 mSv/MBq in men and 0.014 mSv/M

81 The effective dose equivalent was 0.018 mSv/MBq (0.065 rem/mCi), and t

82 The effective dose equivalent was 0.018 mSv/MBq (0.068 rem/mCi).

83 The effective dose equivalent was 0.022 mSv/MBq (80 mrem/mCi).

84 as the kidneys (0.52 mGy/MBq); the effective dose equivalent was 0.1 mSv/MBq, and the effective dose

85 The average effective dose equivalent was 11.6 +/- 0.6 microSv/MBq (mean +/- S

86 The effective dose equivalent was 3.8 microGy/ MBq in men and 4.8 micr

87 e phantoms, respectively), and the effective dose equivalent was 6.9 +/- 0.6 and 8.7 +/- 0.6 muSv/MBq

88 ty of 17 MBq/kg (0.45 mCi/kg), the effective dose equivalent was about 5 mSv or below for all age gro

89 ersus 0.57 (0.45-0.64)-fold median effective dose equivalent was associated with lower odds of postop

90 asured between 2 and 6 mR/h, and the shallow dose equivalent was calculated as 0.037 mrem per treatme

91 Effective dose equivalent was calculated using ICRP 60 weights.

92 Effective dose equivalent was calculated using International Commi

93 mrem), where 100% of the estimated effective dose equivalents were <5 mSv (500 mrem).

94 Effective dose equivalents were calculated retrospectively using d

95 Effective dose equivalents were similar for the eight- and 16-dete

96 The effective dose equivalent (whole body) from administration of 4.07